Pharmaceutical Technology | Drug Development News & Views …
WEBPharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
Boehringer and Circle Pharma to develop new cancer treatment
WEB1 day ago · Boehringer Ingelheim and Circle Pharma have entered a new research partnership and licence agreement to develop a new precision cancer treatment. The partnership aims to create a first-in-class cyclin inhibitor, potentially offering new hope for patients with hard-to-treat cancers. Uncontrolled cell growth is a hallmark of most …
Magazine: Cell and gene therapy approvals drive paradigm …
WEB2 days ago · The growing global demand for cell and gene therapies (CGTs) is resulting in a manufacturing paradigm shift, reflecting the need to overcome a range of evolving new challenges and adapt to maintain rigorous safety and efficacy standards. This month’s cover story looks at how the acceleration in ...
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
WEBAug 20, 2024 · Pharmaceutical companies are increasingly harnessing artificial intelligence (AI) to advance research and development, resulting in groundbreaking healthcare solutions. Recent innovations include AI-driven cancer treatment target identification, optimized drug combinations, and automated systems for improved production efficiency …
Pharmaceutical Technology’s most-read stories of 2023
WEBDec 19, 2023 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in …
Pharma breakthroughs: 10 novel drug approvals that made …
WEBDec 20, 2023 · Around 10 million people worldwide will die from cancer every year and approximately 685,000 of those deaths will be due to breast cancer. Orerdu (elacestrant) is a selective oestrogen receptor degrader (SERD) marketed by Stemline Therapeutics – a subsidiary of Menarini in the U.S.
Pharma developments in 2022: what you need to know
WEBJan 5, 2022 · By GlobalData. The Covid-19 pandemic significantly altered the clinical trials landscape, and a Clinical Trials Arena analysis by Andrew and Kezia Parkins shows the frequency of decentralised clinical trials will reach new heights in 2022, with a 28% jump from last year. Looking at the bigger picture, Andrew reports that middle-income …
How technology could transform drug research in 2022
WEBDec 14, 2021 · Pharmaceutical Technology takes a look at some of the tech innovations set to impact drug discovery and development in 2022. When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons. The ambitious and lesser-explored methods currently being applied in …
Unveiling the Top Pharmaceutical Companies Shaping the Industry
WEBThe world’s biggest pharmaceutical companies: Top ten by revenue. From Johnson & Johnson to Bristol Myers Squibb (BMS), Pharmaceutical Technology lists the top ten pharmaceutical companies in 2023, based on their revenues. Irena Maragkou. Top pharma companies in 2023. Image courtesy of Dmitry Kalinovsky/Shutterstock.
The future of cell and gene therapy manufacturing
WEBDec 1, 2023 · The global pharmaceutical industry finds itself at a compelling intersection. The next five years will signify a critical period with the adoption of a combination of technological advancements, strategic partnerships, and major shifts in drug discovery, manufacturing, and distribution.. While the scope of cell and gene therapies continues to …